| http://www.w3.org/ns/prov#value | - During the year, we took major steps toward reaching our strategic goals, including the acquisition of Cephalon which has enabled us to continue the process of establishing a top-notch specialty pharma business; our acquisition of Taiyo which creates an important growth engine for us in Japan, one of the world???s most attractive generics markets; and our JV with Procter & Gamble which significant
|
